Showing results (41-50 of 167) with videos related to

Sort By:
Pageof 17
Health Economics Review|January 17, 2017
Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspectiveKlaus Kaier, Silvia Hils, Stefan Fetzer, et al.
Journal of Agricultural and Food Chemistry|July 20, 2017
Microbial Transglutaminase Used in Bread Preparation at Standard Bakery Concentrations Does Not Increase Immunodetectable Amounts of Deamidated GliadinAndreas Heil, Jürgen Ohsam, Bernard van Genugten, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2007
Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancerP Harter, K Gnauert, R Hils, et al.
Analytical Biochemistry|March 25, 2009
A nonradioactive dot blot assay for transglutaminase activityStephen J McConoughey, Zoya V Niatsetskaya, Ralf Pasternack, et al.
Angewandte Chemie (International Ed. in English)|December 7, 2016
Bottom-Up Meets Top-Down: Patchy Hybrid Nonwovens as an Efficient Catalysis PlatformJudith Schöbel, Matthias Burgard, Christian Hils, et al.
Amino Acids|October 11, 2011
Transglutaminase 6: a protein associated with central nervous system development and motor functionHelen Thomas, Konrad Beck, Magdalena Adamczyk, et al.
Human Immunology|July 28, 2012
Immunological effects of transglutaminase-treated gluten in coeliac diseaseLuca Elli, Leda Roncoroni, Martin Hils, et al.
Oncotarget|December 22, 2017
Regulatory T cells characterized by low Id3 expression are highly suppressive and accumulate during chronic infectionKatharina S Rauch, Miriam Hils, Alexandra J Menner, et al.
The European Journal of Neuroscience|May 8, 2024
Cholinergic modulation of motor sequence learningAngela Voegtle, Catharina Mohrbutter, Jonathan Hils, et al.
Gynecologic Oncology|April 5, 2012
Outcome of immediate re-operation or interval debulking after chemotherapy at a gynecologic oncology center after initially incomplete cytoreduction of advanced ovarian cancerJacek P Grabowski, Philipp Harter, Rita Hils, et al.
Pageof 17